Lv3
350 积分 2024-04-16 加入
Bioengineering strategies to optimize STING agonist therapy
1小时前
已完结
Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pancreatic cancer
9天前
已完结
Combination locoregional and systemic therapies in hepatocellular carcinoma
1个月前
已完结
Shear-thinning biomaterial for endovascular embolization
3个月前
已完结
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study
4个月前
已完结
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study
4个月前
已完结
Combination locoregional and systemic therapies in hepatocellular carcinoma
4个月前
已完结
Temporary Embolic Agents
4个月前
已完结
Design and progress of drug-loading polymeric bead for tumor embolization
4个月前
已完结
Comparative Study of Chemoembolization Loadable Beads: In vitro Drug Release and Physical Properties of DC Bead and Hepasphere Loaded with Doxorubicin and Irinotecan
4个月前
已完结